EXHIBIT 10.32
CTI, INC.
STOCK RESTRICTION AND NON-COMPETITION AGREEMENT
THIS IS AN AGREEMENT made as of this 9th day of April, 2001, by and
between CTI, Inc., a Tennessee corporation (the "Company" or "CTI"), and ▇▇▇▇▇▇
▇▇▇▇ ("Participant").
RECITALS
On October 31, 2000, ▇.▇.▇.▇▇▇ Pharmaceutical Services, Inc.
("▇.▇.▇.▇▇▇ Services") was merged into ▇.▇.▇.▇▇▇ Pharmaceuticals, Inc., a
wholly-owned subsidiary of CTI (the "Merger"). Pursuant to a Merger Agreement
between those parties dated October 10, 2000 ("Merger Agreement"), CTI agreed to
issue CTI stock to the ▇.▇.▇.▇▇▇ Services stockholders and the holders of
Capital Event Stock under the ▇.▇.▇.▇▇▇ Pharmaceutical Services Amended and
Restated Long-Term Incentive Plan. Participant was a stockholder in ▇.▇.▇.▇▇▇
Services and/or a holder of Capital Event Stock in ▇.▇.▇.▇▇▇ Services. Pursuant
to the Merger Agreement, each ▇.▇.▇.▇▇▇ Services shareholder and holder of
Capital Event Stock is required to execute this Agreement to reflect certain
stock restrictions and competition restrictions associated with the ownership of
CTI stock..
In consideration of the foregoing, of the mutual covenants herein
contained and for other valuable consideration, the receipt of which is hereby
mutually acknowledged, the parties hereto agree as follows:
AGREEMENTS
1. STOCK TRANSFER RESTRICTION.
A. No shares of CTI stock issued to Participant to effectuate
the Merger ("Merger Shares") may be sold, transferred or assigned, whether
voluntarily or involuntarily, by operation of law or otherwise, except as
provided herein. Any purported sale, transfer or assignment of Merger Shares
other than in accordance with these provisions shall be null and void ab initio.
B. Merger Shares may be sold, transferred, or assigned (i) in
accordance with SECTION 1.C below, or (ii) by will or the laws of descent and
distribution.
C. Except as permitted by SECTION 1.B above, before any Merger
Shares may be sold, transferred or assigned, such Merger Shares shall first be
offered for sale to the Company in the following manner:
(i) The Participant intending to sell, transfer or
assign Merger Shares shall deliver to the Company a written notice (the
"Notice") of the Participant's bona fide intention to sell, transfer or assign
Merger Shares. The Notice shall specify (a) the proposed buyer or buyers, (b)
the number of Merger Shares to be sold or transferred, (c) the price per share,
and (d) the other terms and conditions upon which the Participant
intends to make such sale or transfer. In the event that any part of the
consideration to be received is other than cash, the Notice shall fully describe
such consideration and state the fair market value thereof. The Company, at its
option and its expense, may in good faith require that the fair market value of
such consideration be determined by an independent appraiser selected by the
Company. In the case of consideration other than cash, the price per share shall
be the fair market value of such consideration as stated in the Notice, unless
the Company exercises its option to require the aforementioned independent
appraisal, in which case the price per share shall be such independently
appraised fair market value.
(ii) Within thirty (30) days after receipt of the
Notice, the Company shall have the prior right to purchase the Merger Shares
described in the Notice at the price and on the other terms and conditions
stated in the Notice. The Company may elect to purchase all (but not less than
all) of the Merger Shares described in the Notice by notifying the offering
Participant in writing within such thirty (30) day period, and tendering payment
to the offering Participant within thirty (30) days after giving such notice,
against delivery of an assignment of the Merger Shares, free and clear of all
liens, claims and encumbrances, duly executed by the Participant in favor of the
Company. In the event an appraisal is requested under paragraph (i) above, the
period for payment shall be extended for so long as is reasonably necessary to
obtain the appraisal report.
(iii) If the Company does not elect to purchase all
of the Merger Shares described in the Notice as provided in paragraph (i) above,
the Company shall be deemed to have waived its right to acquire such Merger
Shares, and the Participant may sell, assign or transfer such Merger Shares
within the sixty (60) day period following the date of the Notice, provided that
any such sale or transfer is strictly in accordance with the terms and
conditions specified in the Notice. Any Merger Shares so transferred shall
continue to be subject to the right of first refusal provided for herein and the
other terms and conditions hereof. Any such transfer must also be in compliance
with applicable securities laws. If the offering Participant does not sell or
transfer all of the Merger Shares described in the Notice within the aforesaid
sixty (60) days, the Merger Shares shall again become subject to the right of
first refusal provided for herein.
(iv) The foregoing restrictions on transfer of Merger
Shares shall terminate upon the sale by the Company of its common stock in an
offering to the public pursuant to a registration statement filed under the
Securities Act of 1933, as amended, underwritten on a firm commitment basis by
an underwriter of nationally recognized standing and yielding gross proceeds to
the Company of at least $35,000,000.
2. COMPETITION RESTRICTIONS.
A. Except as otherwise provided herein or as determined by the
Board of Directors of CTI, until the later of (i) March 15, 2001, or (ii) the
date Participant ceases to hold CTI stock, neither the Participant nor his/her
Affiliates (as defined below) shall engage, directly or indirectly, in the
United States in the business of owning or operating PET Centers (as defined
below) and the Participant and his/her Affiliates shall present to the Company
any and all opportunities known to the Participant and his/her
2
Affiliate, or to which the Participant and his/her Affiliate becomes privy, and
in which the Participant and his/her Affiliate has an interest in pursuing
pertaining to the acquisition, ownership, or operation of, or investment in, any
PET Centers in the United States. If the Company or its Affiliates are unable or
fail for any reason to pursue a particular opportunity, or if the Board of
Directors determines that the Company or its Affiliates shall not pursue a
particular opportunity, the Participant or his/her Affiliate which presented
such opportunity to the Company shall be free to pursue said opportunity without
restriction, and neither the Company nor the other shareholders or their
Affiliates shall have any right or interest in or with respect to such
opportunity.
B. For the purposes hereof, "Affiliate" means as to any person
or entity, a director of such an entity, or any other person or entity who,
directly or indirectly, through one or more intermediaries, Controls or is
Controlled by or under common Control with that entity. For the purposes hereof,
"Control," "Controls," or "Controlled" (and derivatives thereof) means as to a
corporation the right to exercise, directly or indirectly, more than 50% of the
voting rights in the corporation, and as to any other entity the possession,
directly or indirectly, of the power to direct or cause the direction of the
management or policies of the same. For purposes hereof, "PET Center" means
positron emission tomography compound manufacturing and distribution centers.
3. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
inure to the benefit of the parties hereto and any successors to the business of
the Company, but neither this Agreement nor any rights hereunder shall be
assignable by the Participant.
4. GOVERNING LAW. The validity, construction, interpretation and effect
of this Agreement shall exclusively be governed by and determined in accordance
with the laws of the State of Tennessee, except to the extent preempted by
federal law.
THIS AGREEMENT is executed as of the day and year first above written.
CTI, Inc.
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
-----------------------------
Title: Secretary
--------------------------
/s/ ▇▇▇▇▇▇ ▇▇▇▇
---------------------------------
Participant
3
